Market Exclusive

IDEXX Laboratories, Inc. (NASDAQ:IDXX) reported earnings of $0.87 per share beating Walls Streets expectations.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) reported Q2 2017 earnings this Morning, coming in at $0.87 per share, beating Wall Street’s estimates of $0.85 per Share. Revenue for the quarter came in at $508.90 million beating analyst estimates of $502.44 million

Analyst Coverage For IDEXX Laboratories, Inc. (NASDAQ:IDXX)
These are 2 Sell Ratings, 2 Hold Ratings, 3 Buy Ratings .
The current consensus rating for IDEXX Laboratories, Inc. (NASDAQ:IDXX) is Hold (Score: 2.14) with a consensus target price of $170.75 , a potential (2.58% upside)Recent Insider Trading for IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Recent Trading for IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares of IDEXX Laboratories, Inc. closed the previous trading session at 157.70 down -8.76 -5.26% with 578,514 shares trading hands.

Exit mobile version